Skip to main content
  • 1823 Accesses

Abstract

Clinical signs and features include:

Rare dermatitis that occurs mostly in patients with α-cell tumor of the pancreas (glucagonoma) that usually occurs in the fifth to sixth decade and presents with frequency of 1:20,000,000 persons/year

Rash comes in waves of irregular erythematous lesions with visible scale with subsequent necrosis and crusting of the epidermis in the center of the lesions leading to bullae

Central healing ultimately occurs giving the lesions an annular appearance; the process for development to healing is about 2 weeks

Predilection for intertriginous sites and areas subject to pressure and frictions (e.g., perineum, groin, buttocks, lower abdomen, and lower extremities)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Chastain MA. The glucagonoma syndrome: a review of its features and a discussion of its perspectives. Am J Med Sci. 2001;321:306–20.

    Article  PubMed  CAS  Google Scholar 

  2. Fedeles F, Murphy M, Rothe MJ, Grant-Kels JM. Nutrition and bullous skin disease. Clin Dermatol. 2010;28:627–43.

    Article  PubMed  Google Scholar 

  3. van Beek AP, de Haas ER, van Vloten WA, et al. The glucagonoma syndrome and necrolytic migratory erythema: a clinical review. Eur J Endocrinol. 2004;157:531–7.

    Article  Google Scholar 

  4. Otto AI, Marshalks M, Zalatnai A, et al. Glucagon cell adenomatosis: a new entity associated with necrolytic migratory erythema and glucagonoma syndrome. J Am Acad Dermatol. 2011;65:458–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Liam Zakko .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Zakko, L., Finch, J., Rothe, M.J., Grant-Kels, J.M. (2013). Necrolytic Migratory Erythema. In: Wu, G., Selsky, N., Grant-Kels, J. (eds) Atlas of Dermatological Manifestations of Gastrointestinal Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6191-3_56

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6191-3_56

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-6190-6

  • Online ISBN: 978-1-4614-6191-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics